Clinical Trials
16 trialsNCT00001452 2026-05-01
Defining the Genetic Basis for the Development of Primary Pigmented Nodular Adrenocortical Disease (PPNAD) and the Carney Complex
National Institutes of Health Clinical Center (CC)
Completed
NCT00005927 2026-03-24
Study of Adrenal Gland Tumors
National Institutes of Health Clinical Center (CC)
Completed
NCT05307328 2025-10-08
RESCUE
Sparrow Pharmaceuticals
Phase 2 Completed
NCT04308590 2025-09-04
GRADIENT
Corcept Therapeutics
Phase 3 Completed
NCT03697109 2025-07-16
GRACE
Corcept Therapeutics
Phase 3 Completed
NCT04373265 2024-02-23
Study of Relacorilant in Combination With Pembrolizumab for Patients With Adrenocortical Carcinoma Which Produces Too Much Stress Hormone (Cortisol)
Corcept Therapeutics
Phase 1 Completed
NCT05347979 2023-02-09
Effect of Relacorilant on the Pharmacokinetics of the Sensitive P-glycoprotein Substrate Dabigatran Etexilate in Healthy Participants
Corcept Therapeutics
Phase 1 Completed
NCT02468193 2020-05-06
Study of Efficacy and Safety of Osilodrostat in Cushing's Syndrome
Novartis
Phase 2 Completed
NCT02804750 2019-10-15
Study to Evaluate CORT125134 in Participants With Cushing's Syndrome
Corcept Therapeutics
Phase 2 Completed
NCT02574793 2018-01-23
Glycemic Fluctuations in Newly Diagnosed Growth Hormone-Secreting Pituitary Adenoma and Cushing Syndrome Subjects
Huashan Hospital
Completed
NCT01676025 2017-10-06
PRA
Seoul National University Hospital
Phase NA Completed
NCT02618694 2017-03-03
PostLapAdrnl
Suez Canal University
Phase NA Completed
NCT00936741 2014-04-02
An Extension Study of CORLUX in the Treatment of Endogenous Cushing's Syndrome
Corcept Therapeutics
Phase 3 Completed
NCT01371565 2014-03-18
Compassionate Use of CORLUX® (Mifepristone) in the Treatment of Signs and Symptoms of Endogenous Cushing's Syndrome
Corcept Therapeutics
Phase 3 Completed
NCT01959711 2013-10-10
Randomized Clinical Trial of Posterior Retroperitoneoscopic Adrenalectomy Versus Lateral Laparoscopic Adrenalectomy
Jagiellonian University
Phase 4 Completed
NCT00569582 2013-08-22
SEISMIC
Corcept Therapeutics
Phase 3 Completed